Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

Japanese journal of ophthalmology, 2023-05, Vol.67 (3), p.264-279 [Peer Reviewed Journal]

Japanese Ophthalmological Society 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2023. Japanese Ophthalmological Society. ;ISSN: 0021-5155 ;EISSN: 1613-2246 ;DOI: 10.1007/s10384-023-00979-8 ;PMID: 36897413

Digital Resources/Online E-Resources